Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Harrow Inc's Business Segments
Harrow Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
2
Largest Segment
Branded
Total Revenue
$ 71
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2026
- Branded79.4%
- Compounding20.6%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Branded | $ 56 | 79.4% |
| Compounding | $ 15 | 20.6% |
Revenue by Product & Service Category - Q2 FY2026
- Product Sales Net99.9%
- VEVYE41.6%
- IHEEZO22.1%
- Other Products15.6%
- Other Revenues0.1%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product Sales Net | $ 71 | 99.9% |
| VEVYE | $ 29 | 41.6% |
| IHEEZO | $ 16 | 22.1% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Harrow Inc dataset.
Description of Harrow Inc
Harrow Health Inc is a publicly-traded, US-based company that specializes in designing, developing and marketing branded prescription and over-the-counter (OTC) pharmaceutical products. The company was founded in 2017 and is headquartered in Nashville, Tennessee. Harrow Health is led by its CEO, Mark L. Baum, who has over 30 years of experience in the pharmaceutical industry.
The company's business model is centered around the development and commercialization of high-quality, affordable and innovative drug products. Harrow Health focuses primarily on niche markets, targeting pharmaceuticals that are used to treat underserved diseases and conditions. The company has an experienced team of medical professionals, researchers and executives who are committed to driving growth through a blend of branded and generic drug products.
Harrow Health's portfolio includes FDA-approved branded drugs and OTC products for the treatment of hypothyroidism, glaucoma, insomnia, and diminished sex drive among others. The company also has a strong pipeline of products under development, including products targeting dry eye disease, neuropathic pain, and acute migraines.
One of Harrow Health's key strengths is its proprietary technologies - the company has developed unique systems for manufacturing and delivering medications that improve efficiency, reduce waste and reduce overall production costs. This allows Harrow Health to offer its products at competitive prices while maintaining high margins and profitability.
Harrow Health operates through its subsidiaries, ImprimisRx and Park Compounding. ImprimisRx is a compounding pharmacy that specializes in preparing customized medications for patients with specific medical needs. Park Compounding, on the other hand, is focused on developing and testing new formulations, with the goal of improving the effectiveness and tolerability of existing drugs.
Harrow Health's growth strategy includes both organic growth and acquisitions. The company is actively pursuing acquisitions of other pharmaceutical companies and assets that align with its business model and strategic objectives. In addition, Harrow Health is focused on expanding its product offerings and leveraging its existing technologies to launch new products for underserved markets.
Overall, Harrow Health is a dynamic and rapidly-growing pharmaceutical company that is committed to bringing innovative and affordable products to market. With a strong leadership team, proprietary technologies and a robust product pipeline, the company is poised for continued success in the years ahead.
The company's business model is centered around the development and commercialization of high-quality, affordable and innovative drug products. Harrow Health focuses primarily on niche markets, targeting pharmaceuticals that are used to treat underserved diseases and conditions. The company has an experienced team of medical professionals, researchers and executives who are committed to driving growth through a blend of branded and generic drug products.
Harrow Health's portfolio includes FDA-approved branded drugs and OTC products for the treatment of hypothyroidism, glaucoma, insomnia, and diminished sex drive among others. The company also has a strong pipeline of products under development, including products targeting dry eye disease, neuropathic pain, and acute migraines.
One of Harrow Health's key strengths is its proprietary technologies - the company has developed unique systems for manufacturing and delivering medications that improve efficiency, reduce waste and reduce overall production costs. This allows Harrow Health to offer its products at competitive prices while maintaining high margins and profitability.
Harrow Health operates through its subsidiaries, ImprimisRx and Park Compounding. ImprimisRx is a compounding pharmacy that specializes in preparing customized medications for patients with specific medical needs. Park Compounding, on the other hand, is focused on developing and testing new formulations, with the goal of improving the effectiveness and tolerability of existing drugs.
Harrow Health's growth strategy includes both organic growth and acquisitions. The company is actively pursuing acquisitions of other pharmaceutical companies and assets that align with its business model and strategic objectives. In addition, Harrow Health is focused on expanding its product offerings and leveraging its existing technologies to launch new products for underserved markets.
Overall, Harrow Health is a dynamic and rapidly-growing pharmaceutical company that is committed to bringing innovative and affordable products to market. With a strong leadership team, proprietary technologies and a robust product pipeline, the company is poised for continued success in the years ahead.
Harrow Health Inc. is a prominent pharmaceutical company dedicated to delivering innovative and high-quality ophthalmic and pharmaceutical products and services. The company operates across three core segments—Pharmaceutical Products, Vision Care Products, and Analytical and Testing Services—each contributing significantly to Harrow Healths mission of advancing health care solutions for patients and professionals alike. Below, we describe each segment in extensive detail:
1. Pharmaceutical Products Segment
The Pharmaceutical Products Segment of Harrow Health is fundamentally centered on the development and provision of innovative therapeutics aimed at addressing a variety of medical conditions, particularly within ophthalmology. This segment is characterized by multiple product lines which embody the company’s commitment to both prescription medications and over-the-counter (OTC) generics. Key offerings in this segment include:
- ImprimisRx: This is a flagship product line known for its customized compounded medications. ImprimisRx markets specialty medications tailored to meet specific patient needs, which can include unique dosages or formulations that are not available through traditional pharmaceutical channels.
- LessDrops: This innovative line focuses on reducing the number of eye drops that patients need to use. The LessDrops formulation offers a convenient solution for patients who require multiple medications, thereby enhancing adherence and improving overall treatment outcomes.
- Sterile Ophthalmics: Harrow Health provides a broad range of sterile ophthalmic products that are crucial for eye health. These include medications for the treatment of common eye conditions such as glaucoma and infections, ensuring safety and efficacy.
- Customized Compounded Formulations: The ability to create personalized medications is a significant aspect of this segment. Harrow Health’s compounding capabilities allow for tailored therapies that can better meet the needs of individual patients, addressing factors like allergies to ingredients found in standard medications.
- Ophthalmic Injections: This category includes injectable treatments for various ocular conditions, delivering drugs directly into the eye to maximize therapeutic efficacy. These products are essential for treating diseases such as age-related macular degeneration.
Vision Care Products Segment
The Vision Care Products Segment focuses on providing superior vision care solutions, setting a standard for quality and innovation. This segment encompasses a variety of product offerings, including:
- Contact Lenses: Harrow Health produces a range of contact lenses designed for comfort and optimal vision correction. These lenses cater to different user needs, including daily wear, extended wear, and specialty lenses for specific vision corrections.
- Intraocular Lenses (IOLs): The company develops advanced intraocular lenses used in cataract surgeries. These lenses provide patients with various options post-surgery, enhancing visual outcomes and quality of life.
- Surgical Instruments: Harrow Health offers a comprehensive suite of surgical instruments that are utilized in eye surgeries and procedures. These instruments are crafted to meet high standards for precision and reliability, making them essential for ophthalmic surgeons.
- Specialty Services: The segment also provides specialized services including vision screenings and assessments. The company plays a pivotal role in supporting surgical staff through training programs aimed at improving surgical techniques and outcomes.
- Surgical Suite Management: Harrow Health assists clinical facilities in managing their surgical suites efficiently, ensuring that operations run smoothly and safely to deliver optimal patient care.
Analytical and Testing Services Segment
The Analytical and Testing Services Segment is integral to Harrow Healths ability to support its pharmaceutical development and compliance initiatives. This segment is characterized by a variety of critical laboratory services, including:
- Analytical Testing: This service encompasses a wide array of tests designed to ensure that pharmaceutical products meet stringent quality standards. The analytical testing procedures include assessments of potency, purity, and stability.
- Stability Testing: Harrow Health conducts extensive stability testing to determine how the quality of a drug varies with time under the influence of environmental factors such as temperature and humidity. This process is vital for establishing expiration dates and ensuring product integrity.
- Product Development: The segment provides comprehensive support for product development, helping clients navigate the complexities of bringing new medications to market. This service includes formulation development and optimization.
- Clinical Trial Design: Harrow Health assists clients in designing effective clinical trials, ensuring that they are robust and compliant with regulatory expectations. The company offers insights and guidance on structuring trials to yield reliable data.
- Regulatory Support: To ensure compliance with FDA regulations and other applicable standards, Harrow Health provides extensive regulatory support services. This may include preparing necessary documentation and submissions for product approvals.
- Analytical Method Development and Validation: This critical service involves the creation and verification of analytical procedures to ensure accurate measurement and evaluation of pharmaceutical products, which is essential for regulatory compliance.
Conclusion
In summary, Harrow Health Inc. is well-positioned within the pharmaceutical and vision care industries, offering a comprehensive range of innovative products and services. The company’s dedication to quality, innovation, and patient-centered care is evident across its three primary segments: Pharmaceutical Products, Vision Care Products, and Analytical and Testing Services. Each segment plays a crucial role in enhancing patient outcomes and contributing to advancements in healthcare technology and delivery.
1. Pharmaceutical Products Segment
The Pharmaceutical Products Segment of Harrow Health is fundamentally centered on the development and provision of innovative therapeutics aimed at addressing a variety of medical conditions, particularly within ophthalmology. This segment is characterized by multiple product lines which embody the company’s commitment to both prescription medications and over-the-counter (OTC) generics. Key offerings in this segment include:
- ImprimisRx: This is a flagship product line known for its customized compounded medications. ImprimisRx markets specialty medications tailored to meet specific patient needs, which can include unique dosages or formulations that are not available through traditional pharmaceutical channels.
- LessDrops: This innovative line focuses on reducing the number of eye drops that patients need to use. The LessDrops formulation offers a convenient solution for patients who require multiple medications, thereby enhancing adherence and improving overall treatment outcomes.
- Sterile Ophthalmics: Harrow Health provides a broad range of sterile ophthalmic products that are crucial for eye health. These include medications for the treatment of common eye conditions such as glaucoma and infections, ensuring safety and efficacy.
- Customized Compounded Formulations: The ability to create personalized medications is a significant aspect of this segment. Harrow Health’s compounding capabilities allow for tailored therapies that can better meet the needs of individual patients, addressing factors like allergies to ingredients found in standard medications.
- Ophthalmic Injections: This category includes injectable treatments for various ocular conditions, delivering drugs directly into the eye to maximize therapeutic efficacy. These products are essential for treating diseases such as age-related macular degeneration.
Vision Care Products Segment
The Vision Care Products Segment focuses on providing superior vision care solutions, setting a standard for quality and innovation. This segment encompasses a variety of product offerings, including:
- Contact Lenses: Harrow Health produces a range of contact lenses designed for comfort and optimal vision correction. These lenses cater to different user needs, including daily wear, extended wear, and specialty lenses for specific vision corrections.
- Intraocular Lenses (IOLs): The company develops advanced intraocular lenses used in cataract surgeries. These lenses provide patients with various options post-surgery, enhancing visual outcomes and quality of life.
- Surgical Instruments: Harrow Health offers a comprehensive suite of surgical instruments that are utilized in eye surgeries and procedures. These instruments are crafted to meet high standards for precision and reliability, making them essential for ophthalmic surgeons.
- Specialty Services: The segment also provides specialized services including vision screenings and assessments. The company plays a pivotal role in supporting surgical staff through training programs aimed at improving surgical techniques and outcomes.
- Surgical Suite Management: Harrow Health assists clinical facilities in managing their surgical suites efficiently, ensuring that operations run smoothly and safely to deliver optimal patient care.
Analytical and Testing Services Segment
The Analytical and Testing Services Segment is integral to Harrow Healths ability to support its pharmaceutical development and compliance initiatives. This segment is characterized by a variety of critical laboratory services, including:
- Analytical Testing: This service encompasses a wide array of tests designed to ensure that pharmaceutical products meet stringent quality standards. The analytical testing procedures include assessments of potency, purity, and stability.
- Stability Testing: Harrow Health conducts extensive stability testing to determine how the quality of a drug varies with time under the influence of environmental factors such as temperature and humidity. This process is vital for establishing expiration dates and ensuring product integrity.
- Product Development: The segment provides comprehensive support for product development, helping clients navigate the complexities of bringing new medications to market. This service includes formulation development and optimization.
- Clinical Trial Design: Harrow Health assists clients in designing effective clinical trials, ensuring that they are robust and compliant with regulatory expectations. The company offers insights and guidance on structuring trials to yield reliable data.
- Regulatory Support: To ensure compliance with FDA regulations and other applicable standards, Harrow Health provides extensive regulatory support services. This may include preparing necessary documentation and submissions for product approvals.
- Analytical Method Development and Validation: This critical service involves the creation and verification of analytical procedures to ensure accurate measurement and evaluation of pharmaceutical products, which is essential for regulatory compliance.
Conclusion
In summary, Harrow Health Inc. is well-positioned within the pharmaceutical and vision care industries, offering a comprehensive range of innovative products and services. The company’s dedication to quality, innovation, and patient-centered care is evident across its three primary segments: Pharmaceutical Products, Vision Care Products, and Analytical and Testing Services. Each segment plays a crucial role in enhancing patient outcomes and contributing to advancements in healthcare technology and delivery.